EP 4143228 A1 20230308 - ANTIBODY AND USES THEREOF
Title (en)
ANTIBODY AND USES THEREOF
Title (de)
ANTIKÖRPER UND VERWENDUNGEN DAVON
Title (fr)
ANTICORPS ET SES UTILISATIONS
Publication
Application
Priority
- FR 2004349 A 20200430
- EP 2021061451 W 20210430
Abstract (en)
[origin: CA3176664A1] The invention relates to a monoclonal antibody against the interleukin 1-alpha or beta receptor antagonist, known as IL-1RA, said antibody inhibiting the interaction of IL-1RA with the membrane-binding chain thereof, the interleukin-1 receptor.
IPC 8 full level
C07K 16/28 (2006.01); A61P 29/00 (2006.01); G01N 33/53 (2006.01)
CPC (source: EP US)
A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - US); C07K 16/2866 (2013.01 - EP US); G01N 33/6869 (2013.01 - EP US); A61K 2039/505 (2013.01 - US); C07K 2317/76 (2013.01 - EP US); C07K 2317/92 (2013.01 - EP US); G01N 2333/20 (2013.01 - EP US); G01N 2333/545 (2013.01 - EP); G01N 2333/7155 (2013.01 - EP US); G01N 2800/26 (2013.01 - US); Y02A 50/30 (2017.12 - EP)
Citation (search report)
See references of WO 2021219872A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
FR 3109779 A1 20211105; FR 3109779 B1 20230421; CA 3176664 A1 20211104; EP 4143228 A1 20230308; US 2023167179 A1 20230601; WO 2021219872 A1 20211104
DOCDB simple family (application)
FR 2004349 A 20200430; CA 3176664 A 20210430; EP 2021061451 W 20210430; EP 21726057 A 20210430; US 202117921792 A 20210430